Share this

Fight for Sight partners with CSO to fund research in Scotland

Fight for Sight partners with CSO to fund research in Scotland

16th August 2017

The Chief Scientist Office (CSO) of Scottish Government has partnered with Fight for Sight, the UK’s leading eye research charity, to help address age-related eye diseases.

The charity is calling for research applications from Scottish based researchers for a grant of up to £200,000 for up to three years. The grant will support research to help address age-related eye diseases and conditions as well as projects focusing on the association of visual impairment with other long-term conditions, such as dementia, stroke or diabetes.

Dr Alan McNair, Senior Research Manager at the Scottish Government Chief Scientist Office commented:

"CSO is delighted to partner with Fight for Sight in this exciting research funding initiative. Age related eye diseases can severely impact patients and those close to them. Research is essential if we are to develop a better understanding of the impact of these conditions and develop effective new treatments".

Michele Acton, Chief Executive of Fight for Sight commented:

"It is only through funding eye research that we will be able to address age-related sight loss. Partnering with the CSO will bring us closer to our goals to the benefit of people in Scotland and worldwide."

The closing date for Fight for Sight/ CSO Project grant applications is 5pm on 1 November 2017 

Further information, eligibility and online application available here

Fight for Sight

  • Fight for Sight is the leading UK charity dedicated to funding pioneering research to prevent sight loss and treat eye disease. Fight for Sight is funding research at leading universities and hospitals throughout the UK.
  • Major achievements to date include: saving the sight of thousands of premature babies through understanding and controlling levels of oxygen delivery; restoring sight by establishing the UK Corneal Transplant Service enabling over 52,000 corneal transplants to take place; providing the funding for the research leading to the world’s first clinical trial for choroideremia; bringing hope to children with inherited eye disorders by co-funding the team responsible for the world’s first gene therapy clinical trial; and identifying new genes responsible for glaucoma, retinitis pigmentosa, keratoconus and other corneal disorders, and Nance-Horan syndrome.
  • Fight for Sight’s current research programme is focusing on preventing and treating age-related macular degeneration, diabetic retinopathy, glaucoma, cataract and corneal conditions. We are also funding research into the causes of childhood blindness and a large number of rare eye disorders.

Go back to News